Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen

Teicoplanin: an alternative drug for the treatment of COVID-19?

(2020) Sophie Alexandra Baron et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Potential therapeutic agents against COVID-19

(2020) Chih-Chia Lu et al.   Journal of the Chinese Medical Association

Ivermectin Inhibits Bovine Herpesvirus 1 DNA Polymerase Nuclear Import and Interferes With Viral Replication

(2020) Sohail Raza et al.   Microorganisms

The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro

(2020) Leon Caly et al.   ANTIVIRAL RESEARCH

Recognition by host nuclear transport proteins drives disorder-to-order transition in Hendra virus V

(2018) Sarah C. Atkinson et al.   Scientific Reports

Ivermectin: enigmatic multifaceted ‘wonder’ drug continues to surprise and exceed expectations

(2017) Andy Crump   JOURNAL OF ANTIBIOTICS

Ivermectin, ‘Wonder drug’ from Japan: the human use perspective

(2011) Andy CRUMP et al.   PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES

The Pharmacokinetics and Interactions of Ivermectin in Humans—A Mini-review

(2008) Aránzazu González Canga et al.   AAPS Journal